Maxalt-mlt and Flexeril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Maxalt-mlt (rizatriptan benzoate) and Flexeril (cyclobenzaprine hydrochloride). Common drug interactions include pain among females and back disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Maxalt-mlt and Flexeril. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Maxalt-mlt?

Maxalt-mlt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 1,534 Maxalt-mlt users. Check the latest studies of Maxalt-mlt.

What is Flexeril?

Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.



On Jul, 10, 2026

47 people who take Maxalt-mlt and Flexeril together, and have interactions are studied.

Maxalt-mlt and Flexeril drug interactions.

What are the common drug interactions of Maxalt-Mlt and Flexeril, by gender? *:

female:

  1. Pain
  2. Insomnia (sleeplessness)
  3. Depression
  4. Nausea (feeling of having an urge to vomit)
  5. Anxiety
  6. Dizziness
  7. Abdominal discomfort
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)

male:

  1. Back disorder
  2. Headache (pain in head)
  3. Renal failure (kidney dysfunction)
  4. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  5. Pancreatitis (inflammation of pancreas)
  6. Rash
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Memory impairment
  10. Neutropenia (an abnormally low number of neutrophils)

What are the common drug interactions of Maxalt-Mlt and Flexeril, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Asthma
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Circulatory collapse
  4. Dizziness
  5. Fatigue (feeling of tiredness)
  6. Loss of consciousness
  7. Pain in extremity
  8. Pulmonary embolism (blockage of the main artery of the lung)

20-29:

n/a

30-39:

  1. Nausea (feeling of having an urge to vomit)
  2. Pain
  3. Anxiety
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Cystitis interstitial (unknown cause characterized by bladder pain)
  6. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  7. Depression
  8. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  9. Dysuria (painful or difficult urination)
  10. Headache (pain in head)

40-49:

  1. Muscular weakness (muscle weakness)
  2. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  3. Night sweats (sweating in night)
  4. Pelvic discomfort
  5. Pneumonia
  6. Sinusitis (inflammation of sinus)
  7. Snoring
  8. Surgery
  9. Urinary tract infection
  10. Weight decreased

50-59:

  1. Aggression
  2. Arthralgia (joint pain)
  3. Muscular weakness (muscle weakness)
  4. Pain
  5. Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
  6. Sinusitis (inflammation of sinus)
  7. Suicidal ideation
  8. Abdominal pain
  9. Abdominal pain upper
  10. Agitation (state of anxiety or nervous excitement)

60+:

  1. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  2. Back disorder
  3. Insomnia (sleeplessness)
  4. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  5. Nausea (feeling of having an urge to vomit)
  6. Pancreatitis (inflammation of pancreas)
  7. Rash
  8. Cavernous sinus thrombosis (formation of a blood clot in brain)
  9. Sinusitis (inflammation of sinus)
  10. Tooth abscess (pus formation in tooth)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 18 people, 38.30%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 12 people, 25.53%
  3. Pain: 11 people, 23.40%
  4. Nausea (feeling of having an urge to vomit): 8 people, 17.02%
  5. Fibromyalgia (a long-term condition which causes pain all over the body): 7 people, 14.89%
  6. Depression: 6 people, 12.77%
  7. High Blood Cholesterol: 6 people, 12.77%
  8. Stress And Anxiety: 5 people, 10.64%
  9. High Blood Pressure: 4 people, 8.51%
  10. Dry Eyes (lack of adequate tears): 4 people, 8.51%

* Approximation only. Some reports may have incomplete information.

Do you take Maxalt-mlt and Flexeril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Maxalt-mlt and Flexeril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Maxalt-mlt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Flexeril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Maxalt-mlt and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flexeril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rizatriptan benzoate and cyclobenzaprine hydrochloride (the active ingredients of Maxalt-mlt and Flexeril, respectively), and Maxalt-mlt and Flexeril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: